GlassScriptPhysician profile
Corey M Coleman
NPI 1033370390
$10,335.03
in general payments reported to CMS, 2019-2025
17 companies · $3,705 in 2025
The $3,705 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,716 · 2020: $154 · 2021: $386 · 2022: $887 · 2023: $669 · 2024: $1,818 · 2025: $3,705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,000 · Food and Beverage: $2,456 · Travel and Lodging: $736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,000.00 |
| Food and Beverage | $2,455.78 |
| Travel and Lodging | $735.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $4,657.14 | 2020-2025 | Carto 3 |
| Boston Scientific Corporation | $3,252.47 | 2019-2024 | Emblem Mri S-Icd, Resonate El Icd Vr, Watchman Access System |
| Abbott Laboratories | $1,272.65 | 2019-2024 | Aveir, Agilis Hispro |
| Medtronic, INC. | $375.62 | 2022-2025 | Aurora Ev-Icd Mri Surescan |
| Pfizer INC. | $152.31 | 2020-2025 | |
| Medtronic Vascular, INC. | $138.77 | 2019 | |
| Atricure, INC. | $115.06 | 2024 | |
| Sanofi-Aventis U.S. LLC | $79.29 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.87 | 2022-2024 | Jardiance |
| Amgen INC. | $56.82 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $33.00 | 2022-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.48 | 2020-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $29.80 | 2019-2025 | Eliquis |
| Abbvie INC. | $19.15 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $17.29 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $15.43 | 2023 | Xarelto |
| Glaxosmithkline, LLC. | $14.88 | 2025 | Arexvy, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Coleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.